These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1169 related articles for article (PubMed ID: 34592886)
1. Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma. Zhuo X; Chen L; Lai Z; Liu J; Li S; Hu A; Lin Y Bioengineered; 2021 Dec; 12(1):8336-8346. PubMed ID: 34592886 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation. Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014 [TBL] [Abstract][Full Text] [Related]
3. The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma. Chen A; Ding S; Shen X; Lin X Comput Math Methods Med; 2021; 2021():9932088. PubMed ID: 34367321 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment. Yu L; Cao S; Li J; Han B; Zhong H; Zhong R Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738 [TBL] [Abstract][Full Text] [Related]
5. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level. Wang W; Ren S; Wang Z; Zhang C; Huang J Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070 [TBL] [Abstract][Full Text] [Related]
6. System analysis of Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116 [TBL] [Abstract][Full Text] [Related]
7. High TLX1 Expression Correlates with Poor Prognosis and Immune Infiltrates in Patients with Lung Adenocarcinoma. Zhao L; Zheng H; Chen F; Lu H; Yu Q; Yan X; Chen X; Zhang Q; Bu Q Curr Mol Med; 2024; 24(6):801-812. PubMed ID: 37340746 [TBL] [Abstract][Full Text] [Related]
8. GTSE1: A potential prognostic and diagnostic biomarker in various tumors including lung adenocarcinoma. Yan G; Li G; Gao X; Liu J; Li Y; Li J; Zhou H Clin Respir J; 2024 May; 18(5):e13757. PubMed ID: 38715380 [TBL] [Abstract][Full Text] [Related]
9. AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma. Zhang S; Lu Y; Qi L; Wang H; Wang Z; Cai Z Biomed Res Int; 2020; 2020():8571932. PubMed ID: 32904605 [TBL] [Abstract][Full Text] [Related]
10. The role of EMG1 in lung adenocarcinoma progression: Implications for prognosis and immune cell infiltration. Wu X; Wu Z; Xie Z; Huang H; Wang Y; Lv K; Yang H; Liu X Int Immunopharmacol; 2024 Sep; 138():112553. PubMed ID: 38943975 [TBL] [Abstract][Full Text] [Related]
11. NRAS expression is associated with prognosis and tumor immune microenvironment in lung adenocarcinoma. Yan Y; Gao Z; Han H; Zhao Y; Zhang Y; Ma X; Chen H J Cancer Res Clin Oncol; 2022 Mar; 148(3):565-575. PubMed ID: 34746975 [TBL] [Abstract][Full Text] [Related]
12. Correlation between prognostic indicator AHNAK2 and immune infiltrates in lung adenocarcinoma. Zheng M; Liu J; Bian T; Liu L; Sun H; Zhou H; Zhao C; Yang Z; Shi J; Liu Y Int Immunopharmacol; 2021 Jan; 90():107134. PubMed ID: 33168407 [TBL] [Abstract][Full Text] [Related]
13. Upregulation of M6A Reader HNRNPA2B1 Associated with Poor Prognosis and Tumor Progression in Lung Adenocarcinoma. Wang W; Li S Recent Pat Anticancer Drug Discov; 2024; 19(5):652-665. PubMed ID: 37877146 [TBL] [Abstract][Full Text] [Related]
14. Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma. Zhai Y; Zhao B; Wang Y; Li L; Li J; Li X; Chang L; Chen Q; Liao Z BMC Cancer; 2021 Mar; 21(1):213. PubMed ID: 33648465 [TBL] [Abstract][Full Text] [Related]
15. SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma. Zhang X; Wu Z; Ma K BMC Cancer; 2022 Apr; 22(1):406. PubMed ID: 35421944 [TBL] [Abstract][Full Text] [Related]
16. Independent Prognostic Potential of GNPNAT1 in Lung Adenocarcinoma. Zheng X; Li Y; Ma C; Zhang J; Zhang Y; Fu Z; Luo H Biomed Res Int; 2020; 2020():8851437. PubMed ID: 33178836 [TBL] [Abstract][Full Text] [Related]
17. GREB1L overexpression correlates with prognosis and immune cell infiltration in lung adenocarcinoma. Yu Y; Wang Z; Zheng Q; Li J Sci Rep; 2021 Jun; 11(1):13281. PubMed ID: 34168239 [TBL] [Abstract][Full Text] [Related]
18. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma. Guo L; Li X; Liu R; Chen Y; Ren C; Du S Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817 [TBL] [Abstract][Full Text] [Related]
19. Cancer-testis antigen KK-LC-1 is a potential biomarker associated with immune cell infiltration in lung adenocarcinoma. Kang Y; Gan Y; Jiang Y; You J; Huang C; Chen Q; Xu X; Chen F; Chen L BMC Cancer; 2022 Jul; 22(1):834. PubMed ID: 35907786 [TBL] [Abstract][Full Text] [Related]
20. NGEF is a potential prognostic biomarker and could serve as an indicator for immunotherapy and chemotherapy in lung adenocarcinoma. Chen X; Zhang T; He YQ; Miao TW; Yin J; Ding Q; Yang M; Chen FY; Zeng HP; Liu J; Zhu Q BMC Pulm Med; 2024 May; 24(1):248. PubMed ID: 38764064 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]